Polycystic Ovary Syndrome: Laboratory Diagnosis of Hyperandrogenic Status of a Woman (A Review of the Article «The Polycystic Ovary Syndrome: a Position Statement from the European Society of Endocrinology», October 2014)
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 8, Issue 72
Abstract
The article presents the modern laboratory aspects for evaluation of hyperandrogenism according to published in October 2014 document of the European Society of Endocrinology in the diagnosis and treatment of polycystic ovary syndrome «The polycystic ovary syndrome: a position statement from the European Society of Endocrinology».
Authors and Affiliations
O. V. Rykova
Keywords
Related Articles
- EP ID EP215627
- DOI -
- Views 71
- Downloads 0
Correlation of the Structural Changes in the Thyroid Gland with Clinical and Laboratory Parameters in Patients with Diabetes Mellitus Type 2
The article presents the results of the study on the influence of clinical and laboratory parameters on the presence of structural changes in the thyroid gland (TG) of patients with diabetes mellitus (DM) type 2. Objecti...
Diabetic Retinopathy: a New Approach to Drug Treatment
Diabetic retinopathy is a basic microvascular complication of diabetes and the leading cause of blindness in the adult population. A review of the literature on this pathology, a relatively new approach to medical treatm...
What was Known about Diabetes Mellitus in Ancient Times? (to Help Teachers and Students of Schools of Diabetes)
.
The Meaning of Using «The Quality of Life Assessment of Growth Hormone Deficiency in Adults» Questionnaire in Patients with Non-Functional Pituitary Adenomas and Various Tumors of Chiasmosellar Area in Pre- and Postoperative Period
The authors have examined 136 patients with growth hormone deficiency (GHD) of various origins (pituitary tumors and ischemic heart disease — comparison group). The investigation of the quality of life on the basis of GH...
Place of Glibenclamide in the Dialectics of Modern Glucose-Lowering Therapy in Terms of Safety and Cardioprotection
.